The Future of AI in Drug Discovery: Innovations in Virtual Screening and Biomarker Discovery
According to a new report published by Polaris Market Research, the AI in Drug Discovery Market Value is projected to witness robust growth. Global AI in Drug Discovery Market size and share is currently valued at USD 1.99 billion in 2024 and is anticipated to generate an estimated revenue of USD 35.42 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 29.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
We’re thrilled to announce the release of our latest research study titled AI in Drug Discovery Market. The report offers an in-depth comprehension of the rapidly growing market, shedding light on all the key aspects stakeholders need to know. It details AI in Drug Discovery market share, market size, and major market developments. In addition, a thorough examination of the major market trends and opportunities has been provided in the report. Furthermore, the research report covers the market restraints and challenges that may impede the market growth in the coming years.
The research report makes use of both qualitative and quantitive research techniques to offer an in-depth market comprehension. A thorough examination of key market developments, competitive landscape, and shifting consumer behaviors has been provided. The study includes graphical representations to help readers understand the key stats and other information easily. By going through the research report, readers can gain the clarity to make strategic decisions and stay ahead of the competition.
📚 Market Dynamics:
The AI in Drug Discovery market research report examines all the key factors influencing the behavior of sellers and buyers in the market. These include:
✅ Economic Conditions: The study factors in the impact of economic factors such as GDP growth and interest rates on market investments and consumer spending.
✅ Technological Advancements: The report sheds light on the introduction of new products/services, technological advancements, and innovations anticipated to create new opportunities for market participants.
✅ Regulatory Policies: The implementation of new government regulations and policies and their impact on product safety and environmental standards have been provided in the report.
✅ Consumer Trends: The study sheds light on the shifting consumer preferences and demographics and their impact on the demand for new products and services.
Competitive Landscape
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market
📚 Competitive Landscape:
The research report includes a thorough analysis of the AI in Drug Discovery market competitive landscape. It covers all the major market aspects, including company overview, company financials, and revenue sources. Besides, other aspects such as market potential, investment in research and development, application dominance, and product strength and weaknesses have been covered in the study. The study has been prepared using SWOT analysis and Porter’s Five Forces to help readers understand the competitive forces in the market.
Some of the top market players are:
Atomwise Inc.
BenevolentAI
Berg Health (In January 2023, Berg Health acquired by BPGbio Inc.)
BioSymetrics, Inc.
CYCLICA (Acquired by Recursion Pharmaceuticals)
Exscientia
GNS Healthcare (In January 2023, the company Rebranded as Aitia)
Google (DeepMind)
IBM
Insilico Medicine
insitro
📚 Segmental Analysis:
The AI in drug discovery market is segmented based on technology, application, drug type, end-user, and region. By technology, the market includes machine learning, deep learning, natural language processing (NLP), and others. Application-wise, the market is categorized into target identification, drug screening, de novo drug design, and clinical trial optimization. Based on drug type, it is divided into small molecule and biologics. The end-user segment comprises pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions. The market is driven by increasing adoption of AI for faster and more efficient drug discovery, reducing research costs, and improving success rates in clinical trials.
📚 Research Methodology:
The research report uses an extensive research methodology to provide a thorough AI in Drug Discovery market analysis. It uses focus groups to collect crucial information through group interactions. Other primary research techniques used include one-to-one interviews and surveys. The secondary research techniques collect important public data from credible entities, government stats, and research centers. Expert analysts have verified all the information provided in the research report to ensure accuracy and reliability.
Report Answers Questions Such As
➽ What are the AI in Drug Discovery market stats?
➽ How will strategic developments impact the market in the coming years?
➽ Which companies are the front runners in the market?
➽ What are the emerging market trends market participants can capitalize on to generate additional revenue streams?
➽ What should be the entry strategies and marketing strategies for new market participants?
➽ What are the market projections considering production value and capacity?
➽ What is the estimated demand for different product types in the market?
More Trending Latest Reports By Polaris Market Research:
Artificial Tendons and Ligaments Market
Internet of Things (IoT) in Retail Market
Indonesia, Philippines, Malaysia, and Cambodia Debt Collection Software Market